Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
81
Total Claims
$273K
Drug Cost
15
Beneficiaries
$18K
Cost/Patient
Risk Score Breakdown 30/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+530%
Opioid rate vs peers
39.5% vs 6.3% avg
+34%
Cost per patient vs peers
$18K vs $14K avg
+120%
Brand preference vs peers
32.1% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 530% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
39.5%
Opioid Rate
32
Opioid Claims
$22K
Opioid Cost
37.5%
Long-Acting Rate
This provider's opioid prescribing rate of 39.5% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 26 claims · $213K
Generic: 55 claims · $61K
Patient Profile
45
Avg Age
—
Female
3.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data